Fairmount Funds Management’s Zenas BioPharma, Inc. Common Stock ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$18.3M Hold
1,892,806
2.38% 15
2025
Q1
$15M Hold
1,892,806
2.32% 13
2024
Q4
$15.5M Hold
1,892,806
1.54% 17
2024
Q3
$32M Buy
+1,892,806
New +$32M 2.6% 14